Insmed Inc (INSM)
24.80
-1.38
(-5.29%)
USD |
NASDAQ |
Apr 18, 16:00
24.79
0.00 (0.00%)
Pre-Market: 20:00
Insmed Total Assets (Quarterly): 1.330B for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.330B |
| September 30, 2023 | 1.325B |
| June 30, 2023 | 1.439B |
| March 31, 2023 | 1.518B |
| December 31, 2022 | 1.656B |
| September 30, 2022 | 994.82M |
| June 30, 2022 | 1.053B |
| March 31, 2022 | 1.153B |
| December 31, 2021 | 1.244B |
| September 30, 2021 | 1.312B |
| June 30, 2021 | 1.230B |
| March 31, 2021 | 692.39M |
| December 31, 2020 | 796.16M |
| September 30, 2020 | 840.72M |
| June 30, 2020 | 885.36M |
| March 31, 2020 | 676.52M |
| December 31, 2019 | 742.30M |
| September 30, 2019 | 763.12M |
| June 30, 2019 | 802.78M |
| March 31, 2019 | 595.92M |
| December 31, 2018 | 604.56M |
| September 30, 2018 | 661.51M |
| June 30, 2018 | 724.24M |
| March 31, 2018 | 773.15M |
| December 31, 2017 | 462.05M |
| Date | Value |
|---|---|
| September 30, 2017 | 506.21M |
| June 30, 2017 | 165.64M |
| March 31, 2017 | 200.66M |
| December 31, 2016 | 237.96M |
| September 30, 2016 | 276.64M |
| June 30, 2016 | 299.68M |
| March 31, 2016 | 327.71M |
| December 31, 2015 | 356.56M |
| September 30, 2015 | 385.74M |
| June 30, 2015 | 408.51M |
| March 31, 2015 | 206.15M |
| December 31, 2014 | 230.86M |
| September 30, 2014 | 235.44M |
| June 30, 2014 | 150.11M |
| March 31, 2014 | 166.62M |
| December 31, 2013 | 176.50M |
| September 30, 2013 | 189.95M |
| June 30, 2013 | 138.72M |
| March 31, 2013 | 143.02M |
| December 31, 2012 | 153.56M |
| September 30, 2012 | 152.46M |
| June 30, 2012 | 136.05M |
| March 31, 2012 | 133.25M |
| December 31, 2011 | 139.83M |
| September 30, 2011 | 146.07M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
676.52M
Minimum
Mar 2020
1.656B
Maximum
Dec 2022
1.077B
Average
1.053B
Median
Jun 2022
Total Assets (Quarterly) Benchmarks
| NeuroMetrix Inc | 21.42M |
| Intra-Cellular Therapies Inc | 728.30M |
| Rhythm Pharmaceuticals Inc | 332.74M |
| Amylyx Pharmaceuticals Inc | 517.45M |
| AN2 Therapeutics Inc | 138.74M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 1.662B |
| Shareholders Equity (Quarterly) | -331.92M |
| Debt to Equity Ratio | -3.481 |
| Current Ratio | 4.118 |
| Net Debt Paydown Yield | -1.62% |